欧盟评估乳酸肠球菌DSM 22502作为所有动物饲料添加剂的授权更新申诶/h1>
放大字体缩小字体时间?024-03-08 14:05 来源:食品伙伴网 作者: 泽夕
核心提示?024??日,欧盟食品安全局(EFSA)发布消息,欧盟食品安全局(EFSA)发布关于乳酸肠球菌(Enterococcus lactis)DSM 22502作为所有动物饲料添加剂的授权更新申请的评估、/div>
   食品伙伴网讯2024??日, 欧盟食品安全局'a href='//www.sqrdapp.com/news/tag_10.html' class='zdbq' title='EFSA相关食品资讯' target='_blank'>EFSA)发布消息,欧盟食品安全局(EFSA)发布关亍a href='//www.sqrdapp.com/news/tag_1520.html' class='zdbq' title='乳酸相关食品资讯' target='_blank'>乳酸肠球菌(Enterococcus lactis)DSM 22502作为所月a href='//www.sqrdapp.com/news/tag_4566.html' class='zdbq' title='动物相关食品资讯' target='_blank'>动物 饲料添加剁/a>的授权更新申请的评估
  经过评估,专家小组得出结论,该添加剂在授权使用条件下对目标物种、消费者和环境都是安全的。在授权更新的情况下,无需评估添加剂的功效。部分原文报道如下:
  Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of Enterococcus lactis DSM 22502 as a technological feed additive for all animal species. The applicant provided evidence that the additive currently on the market complies with the existing co nditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reco nsider its previous co nclusions regarding the safety and efficacy of the additive. The FEEDAP Panel co ncluded that E. lactis remains safe for all animal species, co nsumers and enviro nment under the authorised co nditions of use. Regarding the user safety, the Panel co ncluded that the additive is not irritating to the skin or eyes. No co nclusions can be drawn on the potential of the additive to cause skin sensitisation, but it is co nsidered to be a respiratory sensitiser. There is no need for assessing the efficacy of the additive in the co ntext of the renewal of the authorisation.
   本文由食品伙伴网食品资讯中心编辑,有任何疑问,请联系news@www.sqrdapp.com、/span>
日期9a href="//www.sqrdapp.com/news/2024-03-08.html">2024-03-08
[ 食品资讯搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map